Evidence map›Paper›PMID 35458105›Full record

ReviewNutrients2022

Inositols, Probiotics, and Gestational Diabetes: Clinical and Epigenetic Aspects.

Ester Vitacolonna, Maria Masulli, Luisa Palmisano, Liborio Stuppia, Marica Franzago

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Chrono-Nutrition: Circadian Rhythm and Personalized Nutrition.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ester VitacolonnaDepartment of Medicine and Aging, School of Medicine and Health Sciences, "G. d'Annunzio" University, Chieti-Pescara, Via dei Vestini, 66100 Chieti, Italy.ORCID 0000-0003-1756-661X
Maria MasulliDepartment of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.
Luisa PalmisanoDepartment of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.
Liborio StuppiaCenter for Advanced Studies and Technology (CAST), "G. d'Annunzio" University, Chieti-Pescara, 66100 Chieti, Italy.
Marica FranzagoDepartment of Medicine and Aging, School of Medicine and Health Sciences, "G. d'Annunzio" University, Chieti-Pescara, Via dei Vestini, 66100 Chieti, Italy.ORCID 0000-0002-4830-8034
University of Chieti-Pescara · ITFederico II University Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing interest in the potential role of different stereoisomers of inositol or their combination as well as probiotics supplementation in healthy glucose metabolism during pregnancy and in promoting offspring health. The aim of this review is to clarify the effects of several inositol and probiotics-based supplements in the prevention and treatment of gestational diabetes (GDM). Moreover, we will discuss the epigenetic aspects and their short- and long-term effects in response to probiotic intervention as well as the possible implications of these findings in guiding appropriate supplementation regimens in pregnancy.

Indexed as

Diabetes, GestationalProbioticsDietary SupplementsEpigenesis, GeneticFemaleHumansInositolPregnancyInositolD-chiro inositolepigenetic regulationfetal programminggestational diabetesMyo-inositolnutritionprobiotics

Identifiers

PMID35458105
PMCPMC9028601
OpenAlexW4224230303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.